Murat Uysal1, Hatice Yılmaz Doğru2, Emrah Sapmaz3, Ufuk Tas1, Bülent Çakmak2, Asker Zeki Ozsoy2, Fatih Sahin4, Safiye Ayan5, Mehmet Esen4. 1. Gaziosmanpasa University, Faculty of Medicine, Department of Anatomy, Tokat, Turkey. 2. Gaziosmanpaşa University, Faculty of Medicine, Department of Obstetrics and Gynecology, Tokat, Turkey. 3. Gaziosmanpaşa University, Faculty of Medicine, Department of Otorhinolaryngology, Tokat, Turkey. Electronic address: emrhils@yahoo.com. 4. Gaziosmanpaşa University, Faculty of Medicine, Department of Emergency Medicine, Tokat, Turkey. 5. Gaziosmanpaşa University, Faculty of Medicine, Department of Biochemistry, Tokat, Turkey.
Abstract
OBJECTIVE: This study aimed to evaluate the effects of rose essential oil on primary dysmenorrhea. METHODS:One hundred patients were randomly divided into two groups; Group D received diclofenac sodium (75 mg/im) and Group A administered diclofenac sodium with aromatherapy (2% rose essential oil). The visual analog scale (VAS) scores in all subjects at baseline, 10th min, and 30th min were recorded. RESULTS: When the two groups were compared before and after the treatment, there were significant decreases in VAS values at the 10 min and 30 min compared to baseline values in both groups (p < 0.001). However, the 30th min mean VAS value in Group D was higher than in Group A (p = 0.019). CONCLUSION: The present study suggests that aromatherapy with rose essential oil, which is a nonpharmacologic treatment method, as an adjuvant to conventional treatment methods may be beneficial for pain relief in individuals with primary dysmenorrhea.
RCT Entities:
OBJECTIVE: This study aimed to evaluate the effects of rose essential oil on primary dysmenorrhea. METHODS: One hundred patients were randomly divided into two groups; Group D received diclofenac sodium (75 mg/im) and Group A administered diclofenac sodium with aromatherapy (2% rose essential oil). The visual analog scale (VAS) scores in all subjects at baseline, 10th min, and 30th min were recorded. RESULTS: When the two groups were compared before and after the treatment, there were significant decreases in VAS values at the 10 min and 30 min compared to baseline values in both groups (p < 0.001). However, the 30th min mean VAS value in Group D was higher than in Group A (p = 0.019). CONCLUSION: The present study suggests that aromatherapy with rose essential oil, which is a nonpharmacologic treatment method, as an adjuvant to conventional treatment methods may be beneficial for pain relief in individuals with primary dysmenorrhea.